Jeffrey Bertolini, an officer of Carlsmed, Inc., filed a Form 144 notice of proposed sale of 747 shares of common stock on November 3, 2026, pursuant to Rule 144 under the Securities Act of 1933.

Key Highlights

  • Proposed sale: 747 shares of Carlsmed, Inc. common stock with an aggregate market value of $11,317.05, according to the filing.
  • Acquisition source: The 747 shares were acquired on November 3, 2026, via a stock option exercise from the issuer, with cash payment on the same date.
  • Shares outstanding: The filing lists 27,302,743 shares of common stock outstanding at the time of notice.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of March 12, 2026.
  • Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, is named as the executing broker.
  • Prior three-month sales: The filing discloses seven prior sales by Bertolini between August 3, 2026, and October 30, 2026, totaling 13,457 shares and $181,955.67 in gross proceeds.

Bertolini's Proposed Sale and Recent Transaction History at Carlsmed

According to the Form 144 filing, Jeffrey Bertolini, identified as an officer of Carlsmed, Inc. (NASDAQ:CARL), filed notice on November 3, 2026, of his intent to sell 747 shares of the company's common stock. The filing states the shares carry an aggregate market value of $11,317.05 and were acquired on November 3, 2026, through a stock option exercise from the issuer, with payment made in cash on the same date. The approximate date of sale listed in the filing is November 3, 2026.

The filing also discloses Bertolini's sales of Carlsmed common stock during the three months preceding the notice. Those transactions, as reported, are: 10,449 shares on August 3, 2026, for gross proceeds of $137,124.32; 787 shares on August 4, 2026, for $10,500.31; 242 shares on August 31, 2026, for $4,048.66; 746 shares on September 3, 2026, for $12,294.08; 243 shares on September 30, 2026, for $3,399.57; 747 shares on October 5, 2026, for $10,749.33; and 243 shares on October 30, 2026, for $3,839.40.

The filing notes a Rule 10b5-1 plan adoption date of March 12, 2026. The notice was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Jeffrey Bertolini. Carlsmed, Inc. is headquartered at 1800 Aston Avenue, Suite 100, Carlsbad, California 92008, and carries SEC File Number 001-42756.

What Was Disclosed

Carlsmed officer Jeffrey Bertolini filed a Rule 144 notice proposing to sell 747 shares of common stock, acquired via stock option exercise, with an aggregate market value of $11,317.05, alongside a record of seven prior sales totaling 13,457 shares over the preceding three months.